Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

BMT/SCT

Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma

New England Journal of Medicine | Dec 19, 2021 BMT/SCT

Biologic and clinical efficacy of LentiGlobin for sickle cell disease

New England Journal of Medicine | Dec 16, 2021 BMT/SCT

Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia

New England Journal of Medicine | Dec 16, 2021 BMT/SCT

Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation

JAMA | Nov 24, 2021 BMT/SCT

Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: An experimental phase I/II multicentre trial

British Journal of Haematology | Nov 18, 2021 BMT/SCT

Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Pediatric Blood & Cancer | Oct 21, 2021 BMT/SCT

Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation

JAMA | Sep 15, 2021 BMT/SCT

Membranous nephropathy with extensive tubular basement membrane deposits following allogeneic hematopoietic cell transplant: A report of 5 cases

American Journal of Kidney Diseases | Sep 11, 2021 BMT/SCT

A new conditioning regimen with chidamide, cladribine, gemcitabine, and busulfan significantly improve the outcome of high‐risk or relapsed/refractory non‐Hodgkin's lymphomas

International Journal of Cancer | Aug 20, 2021 BMT/SCT

Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia

Pediatric Transplantation | Jul 30, 2021 BMT/SCT

« Prev 1 2 3 4 5 … 14 Next »

Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma

Biologic and clinical efficacy of LentiGlobin for sickle cell disease

Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia

Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation

Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: An experimental phase I/II multicentre trial

Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation

Membranous nephropathy with extensive tubular basement membrane deposits following allogeneic hematopoietic cell transplant: A report of 5 cases

A new conditioning regimen with chidamide, cladribine, gemcitabine, and busulfan significantly improve the outcome of high‐risk or relapsed/refractory non‐Hodgkin's lymphomas

Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma

Biologic and clinical efficacy of LentiGlobin for sickle cell disease

Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia

Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation

Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: An experimental phase I/II multicentre trial

Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation

Membranous nephropathy with extensive tubular basement membrane deposits following allogeneic hematopoietic cell transplant: A report of 5 cases

A new conditioning regimen with chidamide, cladribine, gemcitabine, and busulfan significantly improve the outcome of high‐risk or relapsed/refractory non‐Hodgkin's lymphomas

Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic